Skip to main content
. 2011 Aug 9;118(17):4646–4656. doi: 10.1182/blood-2011-03-343947

Table 1.

Comparison of transposon integration sites in normal and malignant T cells

Obs/Exp* χ2 P Obs/Exp* χ2 P
Vav-SB control data (7099 events) CD4-SB control data (11 180 events)
Vav-SB CIS regions (81 832 TA sites) 10/6 0.563 ns 8/6 0.071 ns
CD4-SB CIS regions (191 922 TA sites) 19/15 0.265 ns 14/15 0.035 ns
Vav-SB tumor data (2843 events) CD4-SB tumor data (4447 events)
VavSB CIS regions (81 832 TA sites) 249/1 255.3 < .0001 91/2 84.15 < .0001
CD4-SB CIS regions (191 922 TA sites) 64/3 60.26 < .0001 296/5 289.2 < .0001

Obs/Exp indicates no. of observed and expected insertion events; CIS, common insertion site; TA, potential SB insertion sites; and ns, not significant.

*

Calculation of expected insertion number is based on a total of 162 687 182 TA sites within the mouse reference genome.